Eve Health Group Limited has released a press release.
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
EVE Health Group Limited on 6ix
Story so far
Earlier from EVE Health
- EVE Completes Initial Production of Libbo
- EVE Signs Telehealth Services Agreement with hubMed -Revised
- EVE Signs Telehealth Services Agreement with hubMed
- Medical Science Liaison Appointed
- EVE Raises $1.1m to Accelerate Launches of Dyspro and Libbo
Later from EVE Health
- Launch of Libbo and Activation of Men's Health Platform
- Appendix 4D and Half Year Report
- EVE Advances Reformulated Drugs Targeting Global Markets
- Trading Halt
- EVE Raises $0.9m to Advance Drug Reformulation Strategy
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health